Uncategorized

Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Property

by Business Wire • 2021/06/15 • 0 Comments

SEATTLE--(BUSINESS WIRE)--VISUS THERAPEUTICS ANNOUNCES EXECUTIVE LEADERSHIP APPOINTMENTS IN OPERATIONS, RESEARCH, CLINICAL OPERATIONS AND INTELLECTUAL PROPERTY

Full Story →

← Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference

VisionQuest Uses Artificial Intelligence to Screen 40,000 Patients for Diabetic Retinopathy →

Post navigation